Sandoz product recalled over manufacturing violations
- Recall date
- September 23, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Sandoz, Inc recalls Sandoz Ranitidine Hydrochloride Capsules 300mg 30 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ 08540 Prod…
- Recall number
- D-0129-2020
- FDA classification
- Class II
- Brand / firm
- Sandoz, Inc
- Sold / distributed
- U.S. Nationwide
Why it was recalled
CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Sandoz Ranitidine Hydrochloride Capsules 300mg 30 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ 08540 Product of India NDC 0781-2865-31
Get recall alerts
Free email alert whenever Sandoz, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sandoz, Inc